Director, Medical Communication and Publications Job at International Society on

At Genmab, we are dedicated to building extra[not]ordinary® futures by developing antibody products and breakthrough medicines that aim to change lives and the future of cancer treatment and serious diseases. We strive to create a global workplace where individuals\' contributions are valued and drive innovative solutions to meet the needs of patients, care partners, families and employees. Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We value being authentic, determined to be our best, and focused on delivering meaningful impact while enjoying what we do. Position overview: The Director, Medical Communication and Publications will be a key leader responsible for driving the medical communications and publications strategy and activities across the Hematology portfolio. The role leads the Hematology medical communications and publications team and contributes to strategy development, planning, and execution of high-quality scientific publications. The role collaborates with Medical Affairs, Clinical Development, Clinical Operations, CORE (Center of outcomes research, real world evidence, and epidemiology), Biostatistics, Commercial, Translational & Quantitative Sciences, and external collaborators to implement the medical communications strategy. This role is part of the Global Medical Affairs department and reports to the Senior Director of Medical Communications and Publications. A hybrid model is in place; onsite presence is required 60% (3 days/week) in Plainsboro, NJ. Responsibilities Lead the Hematology Medical Communications team and provide expertise to the matrix team in developing and executing the medical communication plan. Demonstrate strong leadership and collaborate effectively with clinical and scientific experts at Genmab. Maintain a global perspective and ability to work with colleagues across cultures, backgrounds, and geographies. Drive the development, implementation, and execution of a global medical communication and publication plan. Serve as the subject matter expert on publication-related matters, collaborating with internal and external disease-area experts to ensure high-quality analysis, interpretation, communication, and publication planning of data. In developing a strategic publication plan, collaborate with cross-functional global stakeholders; anticipate risks, identify solutions, and adjust plans as healthcare landscapes change. Provide leadership, guidance, and strategic oversight to team members, including direct reports. Manage annual budget and resources, ensuring contracts, SOWs, and invoices are accurate and timely to deliver high-quality outputs. Liaise with agency/vendor partners to ensure timely delivery of quality publications, providing direction, content review, and adherence to Genmab SOPs. Contribute subject matter expertise to the creation or updates of departmental SOPs to improve processes and achieve organizational goals. Be open, engaging, and transparent; navigate conflicts and push back when needed. Qualifications Advanced degree: PharmD, PhD or MD; CMPP desirable. Oncology/Hematology experience strongly preferred. 7+ years in medical writing and relevant industry experience in medical communications. Expertise across all aspects of scientific publication strategy, planning, and execution during drug development and commercialization. Understanding of clinical research principles and disease-state knowledge. Ability to drive and execute within a large matrix, cross-functional team. Strategic thinking at an enterprise level with the ability to navigate ambiguity and fast-paced timelines. Understanding of good publication practices (GPP, ICMJE) and related scientific data communication guidance. Understanding of clinical trial design and execution, statistical methods, and data reporting requirements. Ability to travel domestically and internationally approximately 20% of the time. Salary, Benefits and Wellness For US-based candidates, the proposed salary band is $182,400.00 — $273,600.00. The final offer considers skills, qualifications, experience, and location. Some positions include discretionary bonuses and long-term incentives. Eligible benefits within the first year for regular full-time U.S. employees include: 401(k) Plan: 100% match on the first 6% of contributions Health Benefits: Two medical plan options (including HDHP with HSA), dental, and vision Voluntary Plans: Critical illness, accident, and hospital indemnity insurance Time Off: Paid vacation, sick leave, holidays, and 12 weeks of discretionary paid parental leave Support Resources: Backup care, family support programs, financial wellness tools, and emotional well-being support Additional Perks: Commuter benefits, tuition reimbursement, and a Lifestyle Spending Account About You You are genuinely passionate about our purpose You pursue precision and excellence in your work You believe in a rooted-in-science approach to problem-solving You are a collaborative team player across diverse backgrounds You take pride in enabling the best work of others on the team You can navigate the unknown and be innovative You have experience in a fast-growing, dynamic company or are eager to You work hard and can have fun while delivering results Locations Genmab supports agile working environments where possible, with offices designed for openness and collaboration. Whether on-site or remote, we value connection and teamwork to drive innovation. About Genmab Genmab is an international biotechnology company focused on improving lives through innovative antibody therapeutics. Established in 1999 and headquartered in Copenhagen, we have a global presence across North America, Europe and Asia Pacific. For more information, visit Genmab.com. Genmab is committed to protecting your personal data and privacy. Please review our Job Applicant Privacy Notice for handling your data. For Netherlands-based roles, hiring may start with a fixed-term contract with potential renewal consideration based on performance and business conditions. #J-18808-Ljbffr